Diagnostic and prognostic procedure for chronic kidney disease in a human subject
Developed by: Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Description
|
Description |
Method for diagnosis and prognosis of chronic kidney disease and associated heart disease |
|
Applications |
Diagnosis and prognosis of chronic kidney disease and risk of cardiovascular events in these patients determined by measuring concentrations of at least one of the following in an isolated sample obtained from a patient: 5-oxoproline, glutamate, guanidinoacetate, alpha-phenylacetylglutamine, taurine, trimethylamine N-oxide (TMNO), homocysteine, leucine, threonine, and citrate; additionally, the result will be assessed by comparing the values from these measurements against those of a reference group of healthy subjects. |
|
Protection status |
National patent. Spanish Patent and Trademark Office. |
|
Cooperation requested |
Search for licensees for the patent Search for partners to undertake joint development of the technology |
|
Therapy Area |
Nephrology Cardiology |
|
Technology Area |
Biotechnology and molecular diagnosis |
- Status:
- N/A
- Health technology:
- N/A